Prior antiretroviral therapy experience protects against zidovudine-related anaemia-Reference-Cited by-同舟云学术

Prior antiretroviral therapy experience protects against zidovudine-related anaemia

Published:2007-10 Issue:7 Volume:8 Page:465-471
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Huffam SE,Srasuebkul P,Zhou J,Calmy A,Saphonn V,Kaldor JM,Ditangco R,

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2007.00498.x/fullpdf

Reference14 articles.

1. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database

2. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

3. HIV lipodystrophy

4. 5 World Health Organization.Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings: Towards Universal Access. Recommendations for a Public Health Approach. Geneva, Switzerland, WHO, 2006.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study;BMC Infectious Diseases;2018-01-15

2. A prospective study of haematological changes after switching from stavudine to zidovudine-based antiretroviral treatment in HIV-infected children;International Journal of STD & AIDS;2016-07-11

3. HIV Symptom Burden and Anemia among HIV-Positive Individuals: Cross-Sectional Results of a Community-Based Positive Living with HIV (POLH) Study in Nepal;PLoS ONE;2014-12-31

4. Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens;Journal of the International Association of Providers of AIDS Care (JIAPAC);2014-11-25

5. An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China;Chinese Medical Journal;2014-01-05